FDA

Will AstraZeneca Have a Big Market for Its COVID-19 Therapy?
Motley Fool
Sat, 10/16/21 - 11:27 pm
AstraZeneca
COVID-19
FDA
FDA Panel Unanimously Recommends J&J Booster Shot
BioSpace
Fri, 10/15/21 - 10:40 pm
JNJ
FDA
vaccines
boosters
COVID-19
Roche's Tecentriq crosses the finish line first in adjuvant lung cancer, potentially kicking off gold rush
Endpoints
Fri, 10/15/21 - 10:37 pm
Roche
Tecentriq
non-small cell lung cancer
FDA
Regeneron Antibody Cocktail a Priority for FDA with April Action Date
BioSpace
Fri, 10/15/21 - 12:35 pm
Regeneron
FDA
priority review
COVID-19
antibodies
Merck’s Covid-19 Pill Set for Review by FDA Advisory Panel
Bloomberg
Fri, 10/15/21 - 11:08 am
Merck
FDA
antivirals
COVID-19
molnupiravir
Follow the FDA advisory panel meeting on the J&J Covid vaccine booster
Stat
Fri, 10/15/21 - 10:56 am
JNJ
FDA
vaccines
boosters
COVID-19
FDA advisers unanimously back Moderna booster shot for many Americans
BioPharma Dive
Thu, 10/14/21 - 11:23 pm
FDA
vaccines
Moderna Therapeutics
boosters
Breaking: Biden likely to nominate Verily's Rob Califf to lead the FDA again
Endpoints
Thu, 10/14/21 - 11:16 pm
FDA
Joe Biden
Verily
Robert Califf
Live tracking the FDA advisory panel meeting on Moderna’s Covid vaccine booster
Stat
Thu, 10/14/21 - 10:55 am
FDA
Moderna Therapeutics
boosters
vaccines
COVID-19
Merck carves out path in first-line advanced cervical cancer with new FDA win for Keytruda juggernaut
Endpoints
Wed, 10/13/21 - 10:48 pm
Merck
Keytruda
FDA
cervical cancer
FDA analysis of J&J COVID vaccine booster sets the stage for public hearing
NPR
Wed, 10/13/21 - 10:43 pm
JNJ
vaccines
COVID-19
boosters
FDA
Eli Lilly's Verzenio snags first-in-class FDA approval for early breast cancer. But limited label poses a challenge
Fierce Pharma
Wed, 10/13/21 - 11:07 am
Eli Lilly
Verzenio
FDA
early breast cancer
breast cancer
J&J proposes sliding booster timelines as FDA questions lack of data for Delta, older adults before adcomm
Endpoints
Wed, 10/13/21 - 10:55 am
JNJ
vaccines
boosters
FDA
COVID-19
FDA scientists neutral on Moderna Covid-19 vaccine booster ahead of key meeting
Stat
Tue, 10/12/21 - 11:38 pm
FDA
boosters
vaccines
JNJ
Moderna Therapeutics
Eyes itching from allergies? Ocular's Dextenza wins FDA approval as first monthly implant
Fierce Pharma
Tue, 10/12/21 - 11:47 am
Ocular Therapeutix
Dextenza
allergic conjunctivitis
FDA
CDC sets panel meetings for J&J, Moderna boosters, child vaccines
The Hill
Mon, 10/11/21 - 09:59 pm
CDC
FDA
COVID-19
boosters
JNJ
Moderna Therapeutics
pediatrics
FDA’s accelerated approval program: Is change on the way?
RAPS.org
Mon, 10/11/21 - 09:53 pm
FDA
regulatory
accelerated approval
Alzheimer’s Drug Granted FDA Breakthrough Designation as Space Heats Up
BioSpace
Mon, 10/11/21 - 09:48 pm
Roche
FDA
breakthrough therapy
Alzheimer's disease
gantenerumab
Merck asks FDA to authorize promising anti-COVID pill
NPR
Mon, 10/11/21 - 10:29 am
Merck
FDA
Ridgeback Therapeutics
COVID-19
antivirals
molnupiravir
Protagonist Therapeutics Announces Removal of FDA Clinical Hold on the Rusfertide Clinical Development Program
Yahoo Finance
Mon, 10/11/21 - 10:25 am
Protagonist Therapeutics
clinical trials
FDA
rusfertide
polycythemia

Pages